Your browser doesn't support javascript.
loading
The anticancer drug tamoxifen counteracts the pathology in a mouse model of duchenne muscular dystrophy.
Dorchies, Olivier M; Reutenauer-Patte, Julie; Dahmane, Elyes; Ismail, Heham M; Petermann, Olivier; Patthey- Vuadens, Ophélie; Comyn, Sophie A; Gayi, Elinam; Piacenza, Tony; Handa, Robert J; Décosterd, Laurent A; Ruegg, Urs T.
Affiliation
  • Dorchies OM; Department of Pharmacology, University of Geneva and University of Lausanne, Geneva, Switzerland. olivier.dorchies@unige.ch
Am J Pathol ; 182(2): 485-504, 2013 Feb.
Article in En | MEDLINE | ID: mdl-23332367
Search on Google
Database: MEDLINE Main subject: Tamoxifen / Muscular Dystrophy, Duchenne / Muscular Dystrophy, Animal / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals Language: En Year: 2013 Type: Article
Search on Google
Database: MEDLINE Main subject: Tamoxifen / Muscular Dystrophy, Duchenne / Muscular Dystrophy, Animal / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals Language: En Year: 2013 Type: Article